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Abstract
Background: Extra pulmonary manifestation of tuberculosis (TB) accounts for approximately one-half of TB cases in HIV-
infected individuals with pleural TB as the second most common location. Even though mycobacteria are cleared,
mycobacterial antigens may persist in infected tissues, causing sustained inflammation and chronicity of the disease. The aim of
this study was to explore various mycobacterial antigens in pleural effusions, the impact of HIV infection and CD4+ T-cell
depletion on the presence of antigens, and the diagnostic potential of antigens for improved and rapid diagnosis of pleural TB.
Methods: Pleural fluid specimens were collected from patients presenting with clinically suspected pleural TB, and processed
routinely for culture, cytology, and adenosine deaminase activity analysis. HIV status and CD4+ T-cell counts were recorded.
Pleural fluid mononuclear cells (PFMC) were isolated, and cell smears were stained with acid-fast staining and
immunocytochemistry for various mycobacterial antigens. Real-time and nested-PCR were performed. Patients were
categorized as pleural TB or non-TB cases using a composite reference standard. Performance of the mycobacterial antigens as
diagnostic test was assessed.
Results: A total of 41 patients were enrolled, of which 32 were classified as pleural TB and 9 as non-TB. Thirteen patients had
culture confirmed pleural TB, 26 (81%) were HIV-TB co-infected, and 64% had < 100 CD4+ T-cells/microL. Both secreted and
cell-wall mycobacterial antigens were detected in PFMC. Lipoarabinomannan (LAM) was the most frequently detected antigen.
There was no direct correlation between positive culture and antigens. Cases with low CD4+ T-cell counts had higher bacterial
and antigen burden. By combining detection of secreted antigen or LAM, the sensitivity and specificity to diagnose pleural TB
was 56 and 78%, respectively, as compared to 41 and 100% for culture, 53 and 89% for nested PCR, and 6 and 100% for real-
time PCR.
Conclusion: Mycobacterial antigens were detectable in PFMC from tuberculous pleural effusions, even in cases where viable
mycobacteria or bacterial DNA were not always detected. Thus, a combination of secreted antigen and LAM detection by
immunocytochemistry may be a complement to acid-fast staining and contribute to rapid and accurate diagnosis of pleural TB.
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Background
On a global scale, tuberculosis (TB) is a leading cause of
death from a single infectious agent. In 2018, 10 million
people were estimated to have developed TB disease, and
1.2 million died because of TB. TB remains the number
one cause of death in people living with HIV [1]. In South
Africa, 60% of adult TB cases are HIV positive [1]. Extra-
pulmonary TB accounts for approximately one-fifth of TB
cases in immune-competent individuals and up to one-
half in HIV-infected individuals [2, 3]. In high TB endemic
settings, TB of the pleura occurs in up to 30% of TB pa-
tients, the second most common site of extrapulmonary
involvement following lymph node TB [4]. In the HIV-
infected population, pleural TB is the most common cause
of a lymphocytic pleural effusion [4–6].
The natural history of TB pleural effusion in HIV-
negative individuals is a slow resolution without treat-
ment, although, up to 65% will progress to active TB
within 5 years [7, 8]. However, with HIV-coinfection,
progression to active disease is more frequent and oc-
curs faster. TB pleural effusions, most probably occur as
a result of pleural infection directly from associated par-
enchymal lesions [9–11]. Immunocompetent individuals
are able to mount a strong immune response, and are
thus able to control mycobacterial multiplication [12],
resulting in paucibacillary forms of TB disease [13].
Paradoxically, the immune response of the host is also
responsible for the pathology and chronicity of the dis-
ease. It is believed that, even though mycobacteria are
cleared, mycobacterial antigens persist in the infected
tissue and could be responsible for persistent inflamma-
tion and chronicity of disease [14–17].
The pathogenesis of pleural TB in HIV co-infected TB
cases is not fully understood. Little is known about the
impact of HIV and depletion of CD4+ T-cells on the
pathogenesis of pleural TB, or the identity of the myco-
bacterial antigens persisting in TB pleural effusions.
Studies have shown that people with TB and HIV co-
infection with low CD4+ T-cell counts have detectable
Lipoarabinomannan (LAM) in urine [18]. This implies
that HIV-induced CD4+ T-cell depletion affects the abil-
ity of the host to control mycobacterial replication,
thereby, leading to higher bacillary load and dissemi-
nated disease with higher amounts of mycobacterial an-
tigens at the disease site.
We have previously shown that the expression of myco-
bacterial antigens in pulmonary TB is distinct from that of
extrapulmonary TB [17]. Of note, we have specifically
demonstrated that the secreted mycobacterial antigen
MPT64 is preferentially expressed in and co-localized with
TB lesions, leading to the hypothesis that this protein is
accumulated in inflammatory cells and could be respon-
sible for persistence of disease [17, 19–25]. The detection
of secreted mycobacterial antigen MPT64 by
immunochemistry from the aspirates, effusions or biopsies
has been evaluated as a useful and better diagnostic test
for various forms of extrapulmonary TB [17, 19–25].
The aim of this study was to explore the expression of
various mycobacterial antigens in the cells from pleural
effusions, the impact of HIV infection and CD4 + T-cell
depletion on the accumulation of mycobacterial anti-
gens, and the diagnostic potential of mycobacterial anti-
gens from pleural effusion for improved and rapid
diagnosis of pleural TB.
Methods
Study participants
Pleural fluid analyses were performed on stored samples
from a previous published study [26]. Briefly, patients pre-
senting with pleural effusion and clinical symptoms of
pleural TB admitted to the Dr. George Mukhari Hospital,
Ga-Rankuwa, Pretoria, South Africa during the period 2004–
2005 were recruited into the study. Patients with recent TB
therapy (< 1 year) or treated with corticosteroids, immuno-
suppressive or antiretroviral therapy were not included. HIV
testing was done routinely in pleural effusion patients with
suspected TB. The demographic and clinical data, HIV status
and CD4+ T-cell count were recorded for each patient.
Specimen collection and processing
Thoracocentesis was performed according to clinical
practice at the hospital. The pleural fluid specimens
were processed according to standard laboratory rou-
tines for acid fast bacilli (AFB) staining of smears and
culture (BacT-alert, Org anon, Teknika). The pleural
fluid was also sent for cytological examination and Ad-
enosine deaminase activity (ADA) analysis using a com-
mercial colorimetric assay kit (Diazyme General
Atomics, CA) with a cut-off value for positive test of 30
U/L [27, 28]. At the time of inclusion pleural fluid
mononuclear cells (PFMCs) were isolated from approxi-
mately 200 ml pleural fluid by density gradient centrifu-
gation (Ficoll histopaque 1077, Sigma). Cells were
washed once with isotonic NaCl, and twice with RPMI
with 10% fetal calf serum (FCS) (1640, L-glutamine and
HEPES supl., Sigma), and resuspended in RPMI media
to make a final concentration of 1 × 106 cells/ml. Cells
were cryopreserved in 10%DMSO/90%FCS. Cryovials
were placed in − 80 °C, and then transferred into liquid
nitrogen for long term storage. The cells were shipped
to Haukeland University Hospital, Bergen, Norway for
further analysis. Cryovials were thawed in a 37 °C water
bath until the cell suspension was almost melted. The
cell suspension was then transferred to 5 mL centrifuge
tubes containing RPMI with 10% FCS at 37 °C, centri-
fuged at 350 g for 5 min, and resuspended in RPMI with
10% FCS. Smears were made for Ziehl Neelsen staining
and immunocytochemical staining.
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Immunocytochemical staining
All antibodies used in the study were in-house rabbit poly-
clonal, except for anti-Bacille Calmette- Gu rin (BCG),
which was obtained from DAKO Immunoglobulins,
Copenhagen, Denmark (code B124; lot 063B). Table 1
shows the immunogens used for production of these anti-
bodies, target antigens, how they are named in the manu-
script, and dilutions. The specificity of these antisera has
been determined by earlier studies [21, 29].
Immunocytochemistry was performed by using the
DakoCytomation kit (EnVision + System-HRP; DakoCyto-
mation Denmark A/S, Glostrup, Denmark). The PFMC
smears were passed through graded alcohol and treated
with 3% bovine serum albumin for 5 min. Primary anti-
bodies were added, and the smears incubated for 1 h 15
min. Optimal dilutions were determined by titration. The
smears were incubated with anti-rabbit dextran polymer
conjugated to horseradish peroxidase for 45min. The en-
dogenous peroxidase activity was inhibited by incubating
the smears with hydrogen peroxide for 8 min. Antigens
were visualized by incubation with 3-amino-9-ethylcarba-
zol and hydrogen peroxide containing substrate for 15
min. The smears were counter-stained with hematoxylin.
All incubations were carried out at room temperature and
the smears were washed thoroughly between incubations.
Negative and positive controls were included in all ex-
periments. One smear where the primary antibody was
substituted with antibody diluent, and one smear from a
patient with non-tuberculous pleural effusion were used
as negative controls. One smear from a culture positive
patient with abundant acid-fast bacilli on Ziehl-Neelsen
staining was used as positive control.
Evaluation of immunostaining
The stained slides were evaluated at 10x magnification
using a light microscope and positive signals were
further assessed at 40x magnification. Cells with intra-
cellular granular staining were counted at 10x magnifica-
tion. The whole smear was examined, and the number
of fields counted. The antigen load was quantified by
calculating the number of stained cells per 100 fields.
For diagnostic purpose, a case with any positive signal
was labelled as positive.
Nested polymerase chain reaction (PCR) for IS6110
DNA extraction was performed by adding 400-1000 μL
of the PFMC suspension to a cryotube containing 250 μl
of acid-washed micro-glass beads and ribolysing the
tubes for 45 s. A 123- base pair fragment from IS6110
was amplified using the following primers 5′ CCTGCG
AGCGTAGGCGTCGG 3′ and 5′ CTCGTCCAGC
GCCGCTTCGG 3′. The product was subjected to a sec-
ond round of PCR amplification using the primers 5′
TTCGGACCACCAGCACCTAA 3′ and 5′ TCGGTG
ACAAAGGCCACGTA 3′ to amplify a 92-base pair
fragment. The PCR reaction mixture consisted of 5 μL
DNA, 25 μL Taq master mix (Qiagen), 0.25 μl of each
100 μM primer stock solution, and distilled water to
make a final volume of 50 μl. For the second round of
PCR, 1 μL of the first PCR product was used as template.
The reaction cycle for the first PCR was- 94 °C for 1
min, 68 °C for 1 min, 72 °C for 20 s for 45 cycles, and for
the nested-PCR - 94 °C for 1 min, 58 °C for 1 min, and
72 °C for 20 s for 35 cycles. Both PCR had an initial heat
activation step of 95 °C for 15 min and a final extension
of 72 °C for 10 min. The amplified products were ana-
lyzed in a 3% agarose gel stained with ethidium bromide.
Mycobacterial DNA isolated from bacterial cultures was
used as positive control and a reaction tube where test
template was substituted with distilled water as negative
control in each PCR run. A negative control tube
Table 1 Primary polyclonal antibodies, immunogens used for the production of antibodies, target antigens, the name used in the
study, and dilutions used for immunohistochemistry
Antibody Immunogen Target antigens Study name Dilution
Anti-MPT64 Antigen extracted and purified from the 5 weeks old
culture filtrate of M. tuberculosis with minimal lysis.
The term MPT was introduced by Nagai et al. for the
designation of proteins purified from M.tuberculosis.
The number is based on their relative mobility in
7.7% polyacrylamide gel electrophoresis gels at a
running pH of 9.5 [29].
MPT64 (Rv1980c). Secreted antigen specific
for M.tuberculosis complex organisms.




Anti-Antigen 60 Cell wall antigens of M.tuberculosis. The number is
based on their relative mobility as mentioned above
[29]












Bacterial sonicates of BCG containing both secreted
and cell wall antigens.
Most of the secreted and cell wall antigens
of the M. tuberculosis based on the similarity
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containing RPMI, going through all steps including the
DNA extraction protocol were also included.
Mycobacterial DNA load was estimated based on the
number of nested-PCR positive triplicates from each
sample. Low and high load was defined when PCR was
positive in one of the three, and three of three samples,
respectively. For diagnostic purposes, any positive in the
triplicate was labelled as positive. The gel electrophoresis
image of the nested-PCR results for some of the samples
is shown in Fig. 1.
Real-time PCR
A real-time PCR assay targeting a 103-base pair long
segment of the mycobacterial heat shock protein 65 gene
GroEL2 was performed as previously published by our
group [30]. The target segment was amplified using the
forward primer MycoFP1 (5′ -CGAGGCGATGGACA
AGGT-3′), the reverse primer TB12 (5′ -CTTGTC
GAACCGCATACCCT-3′), and the fluorescent-tagged
Taq Man MGB probe MycoPr1 (5′ -VIC-AACGAG
GGCGTCATCACCGTCG-MGB-3′). The PCR reactions
were set up in a total volume of 20 μl consisting of 10 μL
of 2 × TaqMan Universal PCR MasterMix (Applied Bio-
systems), 5 μL DNA extract from clinical specimen and
a final concentration of each primer and probe of
0.9 μM and 0.25 μM, respectively. Amplification was
done with a 7500 Fast-Real-Time System (Applied Bio-
systems) using the following parameters: 2 min at 50 °C
to activate AMPErase UNG, 10 min at 95 °C to activate
AmpliTaq Gold, followed by 45 thermal cycles of 95 °C
for 15 s and 60 °C for 1 min. Each clinical specimen was
run in technical duplicates or triplicates. To further en-
sure the reliability of results, each run included both
negative controls (5 μL of sterile water) as well as several
positive controls (known dilutions of genomic DNA
from Bacille Calmette- Gue’rin, Mycobacterium spp.
ATCC 19015D). Standard quantification curves were
generated based on the known concentrations of the
positive controls using the Sequence Detection System
software v1.3 (Applied Biosystems). As per recommen-
dations of the manufacturer (Applied Biosystems), real-
time PCR data were analyzed using a threshold set at 10
SDs above background signal level and only threshold
cycle values below 40 were noted as positive.
Patient categories
The patients were categorized by using a composite ref-
erence standard by combining the clinical and laboratory
diagnostic criteria. Pleural TB was defined based on ei-
ther mycobacterial confirmation by AFB microscopy
and/or culture positive pleural fluid, or in the absence of
bacteriological confirmation by clinical criteria based on
ADA ≥30 U/L from the pleural fluid and/or strong clin-
ical evidence consistent with active TB followed by a
clinical decision to treat with anti-tuberculosis therapy
[26]. A case was categorized as non-TB when diagnosed
as malignancy or another non-TB condition.
Statistical analysis
Data was analyzed using Statistical Package for the Social
Sciences for Windows version 25.0. The data was not nor-
mally distributed, thus non-parametric tests were used for
two group comparisons. Wilcoxon signed-ranked test was
used for matched analysis, and Mann–Whitney test was
used for two independent group comparisons. Chi-square
test was used for comparison of ratios between two groups.
Spearman’s rank correlation was used to determine the re-
lationship between variables. A p-value of < 0.05 was con-
sidered significant. Cross-tabulation was used to calculate
the sensitivities and specificities of diagnostic tests.
Ethical considerations
The study was evaluated and approved by the Research,
Ethics and Publications Committee at the Dr. George
Mukhari Hospital, University of Limpopo, South Africa
(2003) and the Regional Committee for Ethics in Medical
Research in Bergen, Norway (2003, REK Vest nr.185.02).
Fig. 1 Gel electrophoresis of the nested-PCR showing PCR
amplification of a 92-bp fragment of IS6110. Results of five samples
are shown, with triplicates from each sample. Only sample 2 and 5
are positive. Lane s.m.; size marker. Neg; negative control. Pos;
positive control
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All the patients received written and verbal information of
the study and all gave informed written consent.
Results
Patient characteristics
Table 2 shows the demographic and laboratory characteristics of
the 41 patients enrolled in the study. Case based information is
provided in Additional file 1. Thirty-two (78%), were classified as
pleural TB cases based on the composite reference standard, and
nine as non-TB cases. Thirteen patients had culture confirmed
pleural TB, 26 (81%) were HIV pleural TB co-infected, and 64%
of these had <100 CD4+ T cells/microL. The median ADA level
was 62U/L. Among non-TB cases, 5 (56%) were HIV positive
and median ADA levels were 15U/L. Seven of the study partici-
pants had a history of previous TB with anti-tuberculous treat-
ment finished more than 1 year before study inclusion.
Culture, PCR and mycobacterial antigens in the pleural
fluid mononuclear cells according to the TB and HIV
status
Among the HIV pleural TB co-infected, the proportion of
culture positive cases was significantly higher as compared to
the HIV-negative pleural TB cases (50% versus 0%, respect-
ively), while the proportion of AFB microscopy, nested-PCR
and real-time PCR was not different (Table 3). Among the
non-TB cases, there was no difference between HIV positive
and HIV negative cases, except for a higher number of posi-
tive for a combination of culture or nested-PCR or any anti-
gen in the HIV positive group (Table 3).
Mycobacterial antigens were observed as intracellular
granular staining in the cytoplasm of pleural fluid mono-
nuclear cells (Fig. 2). There was no difference in the pro-
portion of mycobacterial antigen positive cases or load
of any antigens between HIV positive and HIV negative
pleural TB cases (Table 3). The load of individual anti-
gens varied among pleural TB cases. Heterogeneous an-
tigens were the most abundant (Fig. 3) and were higher
as compared to LAM (p = 0.04) and secreted antigen
(p = 0.02) (Fig. 3). The levels of antigens had a significant
positive correlation with each other, except between het-
erogeneous mycobacterial antigens and cell wall antigen
(Table 4). Interestingly, culture had a tendency towards
negative correlation with all antigens, but the association
was not statistically significant (Table 4).
Table 2 Demographic and laboratory characteristics of patients




Age, median (range) 36 (19–69)
Pleural TB cases 32 (78%)
Diagnosis based on
Culture 13 (41%)
AFB microscopy +, ADA > 30 and clinical evidence 1 (3%)
ADA > 30 and clinical evidence 17 (53%)
Clinical evidence onlyb 1 (3%)
HIV positive 26 (81%)
CD4+ T cell count HIV+, (n) median (range)a (22) 80 (7–328)
CD4+ T cell count > 100 cells/microL 8 (36%)
CD4+ T cell count < 100 cells/microL 14 (64%)
ADA levels U/L (n) median (range)a (29) 62 (4–200)
Non-TB cases 9 (22%)
Malignancy 3 (33%)
Another non-TB condition c 6 (67%)
HIV positive 5 (56%)
CD4+ T cell count HIV+, (n) median (range)a (4) 119 (49–375)
CD4+ T cell count > 100 cells/microL 3 (75%)
CD4+ T cell count < 100 cells/microL 1 (25%)
ADA levels U/L (n) median (range)a (9) 15 (1–29)
n number, aresults were not available for some patients
bADA level just below cutoff
cPleural effusion of other known etiology such as congestive cardiac failure or para-pneumonic effusion
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Association of mycobacterial DNA load with culture,
AFB microscopy and the mycobacterial antigens was
also studied. Cases with higher DNA load had higher
number of culture positive (p = 0.06), microscopy posi-
tive (p = 0.07) and cell wall antigen positive (p = 0.007)
results as compared to those with lower DNA load
(Table 5). Figure 4 shows the load of various antigens
among cases with higher and lower DNA load. The load
of cell wall antigen was higher in the cases with higher
DNA load (p = 0.02), while there was no difference in
the load of any of the other mycobacterial antigens stud-
ied (Fig. 4). Additional file 1 provides case-based
information.
Association of CD4+ T-cell count with the mycobacterial
antigens and bacterial load in pleural TB patients
Pleural TB cases with CD4+ T-cell counts < 100 had
higher number of culture positive cases as compared to
cases with CD4+ T-cell counts > 100 (p = 0.07) (Table 5),
indicating higher viable bacterial load. There was a sig-
nificant negative correlation between the CD4+ T-cell
counts and culture (p = 0.006) (Table 4). The number of
cases positive for cell wall antigen (p = 0.003) and se-
creted antigen (p = 0.04) were also higher in those with
CD4+ T cell count < 100 (Table 5). The load of individ-
ual antigens was higher among cases with CD4+ T-cell
count < 100 as compared to those with CD4+ T-cell
count > 100. The only statistically significant difference
was seen for cell wall antigen (p = 0.01), where this anti-
gen was not detected in cases with higher CD4+ T-cell
counts (Fig. 5). There was a trend towards negative cor-
relation between CD4+ T-cell counts and the mycobac-
terial antigens, though without statistical significance
(Table 4). Additional file 1 provides case-based
information.
Performance of various mycobacterial antigens as
diagnostic test
Using the composite reference standard, sensitivity and
specificity of the individual antigens to diagnose pleural
TB was between 38 and 47% and 56–100% respectively
(Table 6). LAM was the most frequently detected anti-
gen (47%) and was not detected in any of the non-TB
cases. When using culture or the combination of culture
and nested-PCR as reference standard, the sensitivity of
the individual antigens was, in general, higher. Except
for heterogenous antigens, the specificity, was lower as
compared to the composite reference standard.
Among rapid tests, the sensitivity of antigen detection
was better than the AFB microscopy and real-time PCR,
and very close to the nested-PCR. The sensitivity of cul-
ture was 41%. By using a composite antigen detection
approach based on the detection of any of the four
mycobacterial antigens, the sensitivity improved to 72%,
Table 3 Results of various procedures on pleural fluid mononuclear cells
TB cases (n = 32) Non-TB (n = 9)
HIV+ (n = 26) HIV- (n = 6) HIV+ (n = 5) HIV- (n = 4)
AFB microscopy+ n (%) 3 (12%) 1 (17%) 0 (0%) 0 (0%)
Culture+ n (%) 13 (50%) 0 (0%)* 0 (0%) 0 (0%)
Nested PCR+ n (%) 15 (58%) 2 (33%) 1 (20%) 0 (0%)
Real-time PCR+ n (%) 2 (8%) 0 (0%) 0 (0%) 0 (0%)
Mycobacterial antigens by immunocytochemistry
Heterogeneous antigens+ n (%) 11 (42%) 2 (33%) 4 (80%) 0 (0%)
Cell wall antigen+ n (%) 10 (38%) 2 (33%) 1 (20%) 1 (25%)
LAM+ n (%) 13 (50%) 2 (33%) 0 (0%) 0 (0%)
Secreted antigen+ n (%) 9 (35%) 3 (50%) 2 (40%) 0 (0%)
Any antigen+ n (%) 19 (73%) 4 (67%) 4 (80%) 1 (25%)
LAM or secreted antigen+ n (%) 14 (54%) 4 (67%) 2 (40%) 0 (0%)
LAM and secreted antigen+ n (%) 8 (31%) 1 (17%) 0 (0%) 0 (0%)
Heterogeneous antigens stained cells/100 fields median (range) 0 (0–348) 0 (0–66) 8 (0–31) 0 (0–0)
Cell wall antigen stained cells/100 fields median (range) 0 (0–130) 0 (0–19) 0 (0–1) 0 (0–1)
LAM, stained cells/100 fields median (range) 0.5 (0–33) 0 (0–12) 0 (0–0) 0 (0–0)
Secreted antigen stained cells/100 fields median (range) 0 (0–72) 2 (0–12) 0 (0–5) 0 (0–0)
Combinations of antigens and other diagnostic tests
Culture and/or n-PCR and/or any antigen+ n (%) 23 (89%) 5 (83%) 5 (100%)* 1 (25%)
Culture and/or n-PCR and/or LAM n (%) 21 (81%) 4 (67%) 1 (20%) 0 (0%)
*significant difference between HIV positive and HIV negative by Pearson chi-square, p value < 0.05
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which was better than all the other tests, although the
specificity was reduced to 44% (Table 6).
Using culture as a reference standard, the sensitivity of
the individual antigens was better than AFB microscopy
and real-time PCR, but lower than the nested-PCR. By
using a combination of culture and nested-PCR as refer-
ence standard, the sensitivity of antigen detection was
much better than the AFB microscopy and real-time
PCR (Table 6).
Head-to-head comparison of various diagnostic methods
As the different diagnostic tests were positive in different
cases, a head-to-head comparison of all tests was also
performed to show that combination of various tests
gives a better diagnostic yield as compared to a single
test (Table 7). Among the 23 nested-PCR negative cases,
10 more cases were positive with combination of se-
creted antigen and LAM, and 15 more cases with com-
bination of all antigens. A combination of culture,
nested-PCR, and mycobacterial antigens was positive in
28 (88%) of pleural TB cases, indicating added value of
combining various diagnostic tests.
Discussion
In this study, we have shown that PFMC from tubercu-
lous pleural effusions detain secreted and cell wall asso-
ciated mycobacterial antigens. HIV coinfection had an
impact on the bacterial burden, shown by a significantly
higher number of culture positive effusion in the HIV
pleural TB co-infected group. In addition, in the HIV
Fig. 2 Cell smears from the mononuclear cells from tuberculous pleural effusions showing the staining pattern of mycobacterial antigens as
detected by immunocytochemical staining. Staining pattern is intracellular granular in the cytoplasm of pleural fluid mononuclear cells
Fig. 3 The mycobacterial antigen load among pleural TB cases (n = 32) measured by the number of stained pleural fluid mononuclear cells per
100 fields. Wilcoxon Signed Ranks Test for paired samples was used for comparisons
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pleural TB co-infected group, the cases with low CD4+
T cell count had a higher number of culture positives
and higher loads of cell wall antigen and secreted anti-
gen. These findings imply that low CD4+ T-cell counts
impair the host ability to clear the infection, resulting in
persistence of bacilli and accumulation of mycobacterial
antigens. Earlier studies have shown that HIV co-
infected pulmonary TB patients with lower CD4+ T-cell
count have detectable LAM in the urine, indicating
higher burden of LAM with CD4 + T-cell depletion [18].
In our study, the LAM was not significantly higher
expressed in the HIV cases with low CD4+ T-cell count,
while cell wall antigen and secreted antigen was higher.
These differences may be due to the differential accumu-
lation of various mycobacterial antigens at different sites
of infection as shown earlier [17], due to the relatively
small sample size, or due to different affinities and speci-
ficities of the primary antibodies.
Mycobacterial antigens are shown to accumulate in
the infected tissues [17, 19–25, 31]. As antigens accumu-
late as a result of bacterial replication, one would expect
a positive correlation between presence of viable bacteria
and the antigens. However, a tendency towards negative
correlation was seen with cell wall antigens, though the
relationship was not statistically significant. This could
be due to the persistence of antigens in the infected
Table 4 Relationship between culture, nested-PCR, bacterial DNA load, CD4+ T cell count and levels of mycobacterial antigens in
the tuberculous pleural fluid mononuclear cells based on Spearman’s rank correlation. The values shown are the correlation
coefficients
Culture DNA load Heterogeneous antigens Cell wall antigen LAM Secreted antigen
DNA load 0.467b
Heterogeneous antigens 0.198 0.155
Cell wall antigen −0.067 0.270 0.259
LAM 0.217 0.079 0.442a 0.370a
Secreted antigen 0.032 0.088 0.625b 0.663b 0.439a
N-PCR −0.394a − 0.938b − 0.236 −0.117 − 0.110 −0.055
CD4+ T cell count −0.507b −0.341 − 0.184 −0.272 − 0.050 −0.122
aCorrelation is significant at the 0.05 level (2-tailed), bCorrelation is significant at the 0.01 level (2-tailed). N-PCR Nested PCR
DNA load is measured based on the number of positives among triplets from each case
Table 5 Relationship of CD4+ T cell count in HIV-pleural TB co-infected (n = 22,CD4+ T cell count not available for four patients),
and the mycobacterial DNA load in all nested-PCR positive patients (n = 18) with AFB microscopy, culture and the mycobacterial
antigens by Pearson chi-square test
CD4 > 100 CD4 < 100 p-value DNA lowa DNA higha p-value
culture+ 2 9 0.07 2 8 0.06
culture- 6 5 5 3
Microscopy + 0 3 0.15 0 4 0.07
Microscopy - 8 11 7 7
Cell wall antigen+ 0 9 0.003 0 7 0.007
Cell wall antigen- 8 5 7 4
Heterogeneous antigens+ 2 8 0.14 4 5 0.62
Heterogeneous antigens- 6 6 3 6
LAM+ 3 8 0.37 4 5 0.62
LAM- 3 6 3 6
secreted antigen+ 1 8 0.04 2 5 0.47
secreted antigen- 7 6 5 6
N-PCR+ 3 9 0.22
N-PCR- 5 5
RT-PCR+ 0 2 0.26 0 2 0.23
RT-PCR- 8 12 7 9
N-PCR Nested PCR, RT-PCR Real time PCR
aDNA load is based on the number of positives among triplets from each case, low = 1/3, high = 3/3 positive
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Fig. 4 Difference in the mycobacterial antigen load among cases with higher and lower DNA load (n = 18). Mycobacterial DNA load is
categorized based on the number of positives with nested-PCR among the triplets from each specimen. Mann-Whitney test was used
for comparisons
Fig. 5 Difference in the mycobacterial antigen load among pleural TB cases according to the CD4+ T cell count (n = 27, CD4+ T cell count not
available for five cases). Antigen load is measured by the number of stained pleural fluid mononuclear cells per100 fields. Mann-Whitney test was
used for comparisons
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cells, while bacteria are killed with the advent of an apt
immune response, as shown previously in the murine
pulmonary TB lesions [31]. These accumulated antigens
could play a role in the persistence of inflammation and
chronicity of disease. This may explain the low yield of
culture in pleural TB, where pathology is sustained by
antigens rather than viable bacteria, underlining the im-
portance of measuring antigens in culture negative cases
when TB diagnosis is uncertain.
The secreted antigen MPT64 constitutes a small frac-
tion of the secreted antigens in in vitro culture filtrates
[29]. On the other hand, in vivo it is detectable in quan-
tities comparable to other major cell-wall associated anti-
gens. This is most probably due to accumulation of this
antigen in the infected cells. Our previous study on pleural
biopsies from the same hospital have shown that this anti-
gen is detectable in 80% of the pleural TB biopsies, while
only 20% of these biopsies were positive with culture [19].
In the present study, this antigen was detected in 38% of
cases, which is much lower as compared to other studies
using the same antibody [20, 23, 25]. This could be due to
the isolation and storage of cells before staining in this
study. The freeze-thaw process could have resulted in the
degradation of antigen. In other studies, the smears were
prepared from fresh specimens which were fixed
immediately.
LAM is a promising mycobacterial antigen detection
test for pulmonary TB in HIV TB co-infected patients
[18]. In our study, LAM was the most abundant antigen
in the PFMC and was detectable in 47% of pleural TB
cases. By combining detection of secreted antigen or
LAM, 56% of cases were detected, which is higher than
other tests used in TB diagnostics. The specificity of this
combination was 78% compared with 100% for detection
of LAM alone. Thus, antigen detection by immunocyto-
chemistry is a robust and rapid test and may assist the
clinical decision to start treatment before culture results
are available. This would reduce diagnostic delay and
curb empirical over-treatment in the absence of bacterial
confirmation. Unlike PCR, this method is not sensitive
to contamination and can be implemented in a basic
pathology lab in high TB endemic settings, without the
need for high tech equipment. However, this needs to be
evaluated on a larger sample to ensure reproducibility.
One disadvantage of the antigen detection by im-
munocytochemistry was the number of false positive
tests. This could be caused by non-specific binding of
the antibodies. However, some results could be true pos-
itives, as implied by the higher false positivity in the HIV
positive cases. TB is a common co-morbidity in high TB
endemic settings, and due to atypical clinical presenta-
tion of TB in HIV co-infected patients, some cases could
be misdiagnosed in the absence of bacteriological
confirmation.
Pleural TB is known to be a paucibacillary disease and
this is also confirmed in our study, as only 12% of the
cases were positive with direct microscopy, 41% with
culture, and only 6% with real-time PCR. The low sensi-
tivity of real-time PCR is similar to the results of Xpert
MTB/RIF assay on pleural effusions [20]. WHO has not
recommended the Xpert MTB/RIF assay for diagnosis of
pleural effusions due to low sensitivity [32]. Nested-PCR
was positive in 53% cases. However, this PCR is not suit-
able for routine use in high TB endemic setting due to
risk of contamination. Even though there was positive
correlation between the cases positive with culture and
DNA load, there was a negative correlation between cul-
ture positivity and nested-PCR. This finding implies that
Table 6 Diagnostic validity of different tests performed on pleural fluid samples by using three reference standards
CRS Culture Culture & N-PCR
SN SP SN SP SN SP
Culture 41 100
Nested-PCR 53 89 77 71
Real-time PCR 6 100 15 100 12 100
AFB Microscopy 12 100 23 96 23 100
Mycobacterial antigens
Cell wall antigen 38 78 31 64 41 71
LAM 47 100 54 71 53 75
Heterogeneous antigens 41 56 54 64 47 62
Secreted antigen 38 78 39 68 35 67
Secreted antigen or LAM 56 78 54 54 59 58
Any 4 antigens 72 44 69 32 76 37
Culture, nested-PCR or any antigen 88 33
Culture, nested-PCR or LAM 78 89
CRS Composite reference standard, SN Sensitivity, SP Specificity
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DNA might persist in the tissues, even if the bacilli are
killed as shown previously in murine tissues [33].
Conclusion
Mycobacterial antigens were detectable in PFMC from
tuberculous pleural effusions by immunocytochemistry.
There was no direct correlation between antigens and
culture, implying that antigens persist in the infected tis-
sues despite clearance of bacilli. More cases can be diag-
nosed by combination of antigen detection and culture.
A combination of LAM and secreted antigen could diag-
nose more cases of pleural TB as compared to all the
routine tests. This immunocytochemistry-based method
is rapid and robust, and unlike PCR, it is not sensitive to
contamination. Hence, it can contribute to the timely
management of pleural TB cases in high TB and HIV
endemic settings. Further studies are required to test the
reproducibility of the test.
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